Biotech

  1. Industry Sectors
  2. Biotech
Find Biotech companies London ads at NewsNow Classifieds/Jobs
Pfizer Steps Further In The Door For Gene Therapies Seeking Alpha05:38
Harry Boxer: 3 biotech stocks with momentum MarketWatch15:46 22-Mar-19
Biogen needs M&A after mammoth Alzheimer's blow: analysts FiercePharma19:48 22-Mar-19
3 Biotech Stocks Insiders Are Buying Seeking Alpha23:34 22-Mar-19
Is Biogen a Bad-News Buy Now? The Motley Fool21:04 21-Mar-19
Health Care Sector Update for 03/22/2019: LXRX,SNY,IRWD,IMMP,CNAT Nasdaq20:21 22-Mar-19
3 Biotechs Among 4 Charts to Watch Nasdaq14:39 22-Mar-19
FDA warns myeloma doctors of Venclexta's doubled death risk FiercePharma16:56 22-Mar-19
Turning Point Therapeutics eyes $100M IPO to propel drug-resistant tumor drug FierceBiotech15:12 22-Mar-19
One day after aducanumab disaster, Eisai kick-starts backup Alzheimer’s drug trial FierceBiotech12:10 22-Mar-19
Seedcorn funding to boost Scotland’s ‘bio-revolution’ Daily Business Group07:06 22-Mar-19
New approach to treat eye cancer European Biotechnology News05:58 22-Mar-19
Choose date and time: ×
In the last hour
2 Biotech Takeout Targets Perfect for Biogen The Motley Fool14:12
In the last 4 hours
Sterling Biotech case: Court allows ED to send LRs to 21 countries for assistance in ₹8,100 crore bank fraud case The Hindu11:42
ED gets court's nod to send LRs to 21 countries in bank fraud case AniNews.in11:11
Early-stage funding boost confirmed for Scotland's biotechnology sector The National, Scotland11:08
In the last 6 hours
Immuno Biotech staff ‘were ‘brainwashed’ claims defence The Guernsey Press & Star10:10
Delhi court allows ED to send LRs to 21 countries for help in Rs 8,100 cr Sterling Biotech case DNA India09:21
Earlier today
Pfizer Steps Further In The Door For Gene Therapies Seeking Alpha05:38
City of Baltimore files lawsuit against AbbVie to recover millions in damages WMAR2News02:17
Berkeley pet food startup lands 'Shark Tank' deal with Mark Cuban ABC7 / KGO-TV01:00
Activist Legion Partners Wants NN to Change Its Name Barron's Online00:10
US IPO Week Ahead: Houston we have Lyft off Nasdaq00:07
Yesterday
3 Biotech Stocks Insiders Are Buying Seeking Alpha23:34 22-Mar-19
Trevena Brings Clarity To Investors Seeking Alpha23:34 22-Mar-19
Cancer biotech Hookipa Pharma files for a $86 million IPO Nasdaq23:16 22-Mar-19
Motif Ingredients Joins Food-Tech Innovation With $90M In Funding CleanTechnica23:00 22-Mar-19
Neuralstem Reports Year End 2018 Fiscal Results GlobeNewswire20:31 22-Mar-19
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire20:31 22-Mar-19
Sterling Biotech loan fraud accused Hitesh Patel nabbed in Albania; to be ‘extradited’ Indian Express20:28 22-Mar-19
Health Care Sector Update for 03/22/2019: LXRX,SNY,IRWD,IMMP,CNAT Nasdaq20:21 22-Mar-19
Biogen-Eisai partnership may be hitting a rough patch following Alzheimer’s drug blowup STAT20:14 22-Mar-19
Dermira Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase… GlobeNewswire20:11 22-Mar-19
3 Key Takeaways From BeiGene's CEO The Motley Fool19:55 22-Mar-19
Biogen needs M&A after mammoth Alzheimer's blow: analysts FiercePharma19:48 22-Mar-19
A troubled timeline of Alzheimer’s trials Biopharma Reporter19:41 22-Mar-19
Health Care Sector Update for 03/22/2019: IRWD,IMMP,CNAT Nasdaq18:58 22-Mar-19
FDA warns myeloma doctors of Venclexta's doubled death risk FiercePharma16:56 22-Mar-19
2018 Annual Report and Accounts and Notice of AGM GlobeNewswire16:08 22-Mar-19
FG warns on dangers of unregulated genetically modified products Vanguard, Nigeria16:04 22-Mar-19
Harry Boxer: 3 biotech stocks with momentum MarketWatch15:46 22-Mar-19
Celgene and Exscientia ink three year AI drug discovery collaboration PharmaTimes15:45 22-Mar-19
Could proxy advisers sway votes against BMS-Celgene merger? FiercePharma15:35 22-Mar-19
How Do You Start A Biotech Company? Forbes15:21 22-Mar-19
Turning Point Therapeutics eyes $100M IPO to propel drug-resistant tumor drug FierceBiotech15:12 22-Mar-19
BioTech Pharma Summit: 3rd Annual Biosimilars and Biologics: Rethinking the Patient Perspective on Biosimilars Center for Biosimilars15:03 22-Mar-19
Entrada picks Syntimmune vet Mario Saltarello as CMO; Gene therapy maker Orchard hires Ran Zheng as CTO ENDPOINTS14:54 22-Mar-19
Blue Biotechnology Market 2019 Global Analysis, Share, Trend, Key Players, Opportunities &… Industry Today14:42 22-Mar-19
3 Biotechs Among 4 Charts to Watch Nasdaq14:39 22-Mar-19
AI drug R&D firm Exscientia expands into Japan pharmaphorum14:15 22-Mar-19
Investor Ideas Adds Recent Nasdaq IPO Stocks: Biotech, China-Asia and Energy Sectors - (… Investorideas.com14:07 22-Mar-19
resTORbio, Inc. Announces Closing Public Offering of Common Stock GlobeNewswire14:07 22-Mar-19
Celgene and Exscientia sign AI drug discovery deal in oncology and autoimmunity PMLiVE12:48 22-Mar-19
SELLAS Life Sciences Reports 2018 Financial Results and Provides Business Update GlobeNewswire12:46 22-Mar-19
Bone-marrow focused Imago BioSciences scores $40M in Omega-led round ENDPOINTS12:43 22-Mar-19
Daxor Corporation to Exhibit at the Society of Hospital Medicine (SHM) Annual Conference 2019 GlobeNewswire12:36 22-Mar-19
BioTech Pharma Summit: 3rd Annual Biosimilars and Biologics: An Expert View on Immunogenicity and Biosimilars Center for Biosimilars12:22 22-Mar-19
One day after aducanumab disaster, Eisai kick-starts backup Alzheimer’s drug trial FierceBiotech12:10 22-Mar-19
Eliminate the Bait of Evolving Extinction GMOs Leadership, Nigeria11:42 22-Mar-19
Sterling Biotech case: Hitesh Patel nabbed in Albania over Rs 8,100 crore fraud Business Today11:41 22-Mar-19
Sterling Biotech bank fraud case: Accused in Rs 8,100-cr loan fraud held in Albania Business Today11:38 22-Mar-19
Cyxone Announces Strategic Intent To Position Its Drug Candidate T20K In MS As A Prophylactic… Drugs Discovery Online11:18 22-Mar-19
Sterling Biotech case: Accused Hitesh Patel held in Albania on ED notice The Asian Age10:46 22-Mar-19
Celgene And Exscientia Enter 3-Year Ai Drug Discovery Collaboration Focused On Accelerating… Drugs Discovery Online10:17 22-Mar-19
Breaking up Brexit with Dr Paul Peter Tak European Pharmaceutical Manufacturer10:10 22-Mar-19
Rs 8100 cr bank fraud: Accused Hitesh Patel detained in Albania India Today09:41 22-Mar-19
Scientists clone adorable police dog dubbed 'Sherlock Holmes' Mirror.co.uk09:17 22-Mar-19
Sterling Biotech bank fraud case: Accused Hitesh Patel detained in Albania; to be extradited to India soon Firstpost09:11 22-Mar-19
Sterling Biotech case: Hitesh Patel held in Albania The Times of India09:07 22-Mar-19
Sterling Biotech group case: Hitesh Patel detained in Albania The Times of India09:05 22-Mar-19
Alligator Bioscience's Annual Report 2018 Published PR Newswire (Press Release)08:53 22-Mar-19
Hitesh Patel, accused in Sterling Biotech group case, detained in Albania The Hindu Business Line08:52 22-Mar-19
Sterling Biotech: Accused Hitesh Patel detained in Albania, likely to be extradited to India soon Indian Express08:51 22-Mar-19
Sterling Biotech group case accused Hitesh Patel detained in Albania The Economic Times08:48 22-Mar-19
Sage’s CEO reflects on progress treating postpartum depression and what Biogen’s big… STAT08:38 22-Mar-19
Sterling Biotech bank fraud case: Hitesh Patel detained in Albania The Hindu08:29 22-Mar-19
Jubilant Life's Nanjangud facility may face regulatory action by USFDA The Times of India07:32 22-Mar-19
Seedcorn funding to boost Scotland’s ‘bio-revolution’ Daily Business Group07:06 22-Mar-19
Celyad to Announce Full Year 2018 Financial Results and Host Conference Call GlobeNewswire06:02 22-Mar-19
New approach to treat eye cancer European Biotechnology News05:58 22-Mar-19
AbbVie: Not A Swan, But A Steal At Its Current Price Seeking Alpha05:33 22-Mar-19
Qiming Venture Partners Leads $42M New Round In Chinese Biotech Start-Up China Money Network03:54 22-Mar-19
Biogen halts late-stage trials on Alzheimer’s drug Boston Globe00:54 22-Mar-19
Better Buy: AbbVie vs. Eli Lilly The Motley Fool00:36 22-Mar-19
For Biogen, ‘a massive destruction of market value’ Boston Globe00:34 22-Mar-19
In the last 7 days
Early stage cancer biotech Turning Point Therapeutics files for a $100 million IPO Nasdaq23:15 21-Mar-19
Brainstorm Health: Biogen Alzheimer’s Drug, CVS Meets CBD, New CRISPR Company Fortune22:54 21-Mar-19
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Amarin Corporation plc of … GlobeNewswire22:19 21-Mar-19
Osmotica Pharmaceuticals plc to Provide Fourth Quarter and Full Year 2018 Business and Financial Update on March 27,… GlobeNewswire22:09 21-Mar-19
Alzheimer’s and amyloid: ‘It’s time to do something else’ STAT21:49 21-Mar-19
Is Biogen a Bad-News Buy Now? The Motley Fool21:04 21-Mar-19
Chutes & Ladders—Two senior Genentech executives make the leap to smaller biotechs FierceBiotech20:15 21-Mar-19
Health Care Sector Update for 03/21/2019: LIFE,OGEN,NVCN,NVCN.TO,BIIB Nasdaq20:11 21-Mar-19
Conatus Announces Top-line Results from ENCORE-NF Phase 2b Clinical Trial in NASH Fibrosis GlobeNewswire20:08 21-Mar-19
Sienna Biopharmaceuticals Promotes Alexander Azoy to Chief Financial Officer and Appoints Sean Andrews to Leadership… GlobeNewswire20:08 21-Mar-19
After the blowup of the biggest hope for Alzheimer’s, what’s next in the pipeline? STAT20:02 21-Mar-19
Is Elizabeth Holmes's Deep Voice Just Another Part of Her Scam? Harper's Bazaar19:37 21-Mar-19
Aducanumab Failure: Selectivity for the Toxic Oligomer is Essential to Treating Root Cause of Alzheimer’s Disease GlobeNewswire19:17 21-Mar-19
BioTech Pharma Summit: 3rd Annual Biosimilars and Biologics: Global Biosimilars Require Regional Development Approaches Center for Biosimilars19:15 21-Mar-19
Biogen Tanks, Drags Down Biotechnology Sector ETFs ETF Trends19:10 21-Mar-19
AbbVie Donates $40 Million to Rebuild North Chicago Middle School PR Newswire (Press Release)19:01 21-Mar-19
My mix-and-match career Science Magazine18:22 21-Mar-19
NE Ohio is third-largest region in U.S. for healthcare investments in 2018: BioEnterprise report Cleveland.com18:19 21-Mar-19
Health Care Sector Update for 03/21/2019: OGEN,NVCN,BIIB Nasdaq18:08 21-Mar-19
Steve Tregay’s exit from Forma marked the end of a $757M collaboration with Celgene ENDPOINTS17:55 21-Mar-19
Biogen value drops by $18bn after Alzheimer’s drug failure Biopharma Reporter17:20 21-Mar-19
Alzheimer’s drug failure leaves Biogen in a precarious place STAT17:11 21-Mar-19
What Brexit Effect? UK Biotech Start-Ups Reach Record Numbers Scrip Pharma Intelligence16:49 21-Mar-19
BB BIOTECH AG: Shareholders at the general meeting vote in favor of all proposals and approve… DGAP16:47 21-Mar-19
Plans to boost Scotland’s ‘bio-revolution’ secure seed funding The Scotsman16:37 21-Mar-19
Puma to pay PPD founder Eshelman $22M in defamation suit FiercePharma15:57 21-Mar-19
BioTech Pharma Summit: 3rd Annual Biosimilars and Biologics: Regulator Explains How Denmark Has Achieved Its Biosimilar … Center for Biosimilars15:33 21-Mar-19
WuXi PharmaTech subsidiaries hit regulatory and manufacturing milestone Manufacturing Chemist15:24 21-Mar-19
Founding Forma CEO Steve Tregay follows 61 staffers out the exit, replaced by Genentech strategy vet ENDPOINTS15:23 21-Mar-19
How to Build a Better Biotech Stock Portfolio The Motley Fool15:12 21-Mar-19

NewsNow Classifieds » Jobs » Top Searches

view more
© Copyright 1997 - 2019 NewsNow Publishing Limited. All rights reserved.

No account? Sign up!

  • Bookmark your favourite topics and create your very own NewsNow page.
  • Save publication preferences and your reading history for quick reference.
  • Take this with you whenever and wherever you sign in!
Site View
Publication filters

Headline Density

  • By clicking "OK" or continuing to use this site, you agree that we may collect and use your personal data and set cookies to improve your experience and customise advertising. To see how, and to learn how to control cookies, please read our Privacy Policy and Cookie Policy.
Sorry, no headlines or news topics were found. Please try different keywords.
Rest of site